Temozolomide News and Research

RSS
Four miRNAs may hold vital clue to disease progression in gliobastoma

Four miRNAs may hold vital clue to disease progression in gliobastoma

Giving chemotherapy after radiotherapy delays rare brain tumour growth

Giving chemotherapy after radiotherapy delays rare brain tumour growth

Clinical trials of anti-cancer agent PAC-1 continue to progress with anonymous funding

Clinical trials of anti-cancer agent PAC-1 continue to progress with anonymous funding

Small lipid nanocarrier may deliver chemotherapeutic drug more efficiently to brain tumor cells

Small lipid nanocarrier may deliver chemotherapeutic drug more efficiently to brain tumor cells

DelMar's VAL-083 receives FDA orphan drug designation for treatment of medulloblastoma

DelMar's VAL-083 receives FDA orphan drug designation for treatment of medulloblastoma

Expression of BIRC3 protein associated with poor survival, recurrent disease in GBM patients

Expression of BIRC3 protein associated with poor survival, recurrent disease in GBM patients

New clinical trial launched to test potential drug that could help immune system combat cancer

New clinical trial launched to test potential drug that could help immune system combat cancer

Use of tumor-treating fields along with chemotherapy improves survival in patients with brain tumor

Use of tumor-treating fields along with chemotherapy improves survival in patients with brain tumor

Scientists identify way to sensitize drug-resistant glioblastoma cells to chemotherapy

Scientists identify way to sensitize drug-resistant glioblastoma cells to chemotherapy

TGen: PPF drug could help treat patients with deadly brain cancer

TGen: PPF drug could help treat patients with deadly brain cancer

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

FDA approves expanded indication for Optune device for brain cancer patients

FDA approves expanded indication for Optune device for brain cancer patients

Genetics and race influence patients' response to anticancer drug treatments

Genetics and race influence patients' response to anticancer drug treatments

DelMar presents updated VAL-083 Phase I/II trial data at GBM2015 meeting

DelMar presents updated VAL-083 Phase I/II trial data at GBM2015 meeting

Innovative vaccine therapy shows promise against glioblastoma brain tumors

Innovative vaccine therapy shows promise against glioblastoma brain tumors

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

Structural brain changes found in chemoradiation-treated glioblastoma patients

Structural brain changes found in chemoradiation-treated glioblastoma patients

New technique improves survival time for glioblastoma patients by 50%

New technique improves survival time for glioblastoma patients by 50%

New study suggests that IDH1 gene may be prognostic marker for anaplastic astrocytoma

New study suggests that IDH1 gene may be prognostic marker for anaplastic astrocytoma

ASCO 2015: UH Seidman Cancer Center researchers present data from several new studies

ASCO 2015: UH Seidman Cancer Center researchers present data from several new studies